AQP1 and intracranial hypertension: All these findings support a role for AQP1 in facilitating CP secretion of CSF into the cerebral ventricles, and support the hypothesis of a role for AQP1 inhibitors in treating hydrocephalus and benign intracranial hypertension, which are associated with CFS formation or accumulation [61].